Admin K Antagonist: A Summary

Freedman et al. (2016) discussed that from a meta-analysis of five studies, the researcher concluded that a vitamin K antagonist such as warfarin can reduce stroke by up to 64% and mortality by 26% when compared with a placebo. To be able to prevent stroke related to a-fib the first step is to complete a stroke risk stratification using assessment tool such as the CHA2DS2-VASc. The chad score can help determine if anticoagulation therapy is recommended base of risk factors such has any congestive heart failure, hypertension, patient age, diabetes, prior stroke, vascular disease, and the sex of the patient. If patients are on an OAC, provider need to monitor closely the international normalized ratio. Over the years there has been slight